@article{7a760f7a0642476183ea64abf2f36596,
title = "Do we really need five TNF antagonists? Or more insight into the use of existing options?",
author = "Ruderman, {Eric M.}",
note = "Funding Information: Disclosure statement: E.M.R. has received consulting fees from Abbott Immunology, Amgen/Wyeth and UCB. He has received research funding from Abbott Immunology and Centocor.",
year = "2010",
month = feb,
day = "19",
doi = "10.1093/rheumatology/keq016",
language = "English (US)",
volume = "49",
pages = "1028--1029",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "6",
}